1010.6000 -44.90 (-4.25%)
NSE Sep 26, 2025 15:52 PM
Volume: 64,357
 

logo
Tatva Chintan Pharma Chem Ltd.
25 Jan 2023, 12:00AM
1010.60
-4.25%
ICICI Securities Limited
Tatva Chintan’s Q3FY23 revenue rose 15% YoY / 34% QoQ to Rs1.2bn as SDA revenue recovered to Rs0.6bn, up 6.4% YoY / 5.7x QoQ. However, non-SDA segments, which hitherto performed well, dipped QoQ. The disappointment come from an 800bps QoQ contraction in gross profit margin to 43.8% due to higher bromine and solvent prices, which have subsequently corrected.
Tatva Chintan Pharma Chem Ltd. has gained 42.76% in the last 6 Months
More from Tatva Chintan Pharma Chem Ltd.
Recommended